Targeting neuroinflammation and neurodegeneration in Parkinson’s disease: Emerging natural and synthetic therapeutic strategies
Ageing Research Reviews · 2026-10 · 121 · 103263
DOI: 10.1016/j.arr.2026.103263 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-10. Verfasst von Safia Arbab und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medicine and Engineering Interdisciplinary Research Laboratory of Nursing & Materials/ Nursing Key Laboratory of Sichuan Province, West China Hospita…. Hauptthemen laut MEDLINE: Parkinson Disease, Neuroinflammatory Diseases, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 260 Literaturangaben.
Abstract (Originalsprache)
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder worldwide. It is associated with the ongoing degeneration of dopaminergic neurons in the substantia nigra and the formation of Lewy bodies that contain α-synuclein. These pathological changes lead to abnormalities of motor symptoms (tremor, rigidity, bradykinesia) and non-motor symptoms (cognitive decline, sleep abnormalities, psychiatric abnormalities). The pathogenesis of PD is complex and multifactorial, involving interconnected mechanisms such as oxidative stress, mitochondrial dysfunction, neuroinflammation, impaired autophagy, ferroptosis, and genetic factors. To develop effective therapeutic interventions, these pathways need to be understood. Current treatments, such as levodopa and deep-brain stimulation (DBS), are symptom-based and do not break disease progression. Thus, considerable research efforts have been geared towards finding disease-modifying therapeutic strategies. Natural bioactive compounds, gene-based therapies, stem cell-based therapies, and nanotechnology-assisted drug delivery systems are promising alternatives as suggested by recent advances. Antioxidant compounds like curcumin, resveratrol, and epigallocatechin gallate (EGCG) show promising antioxidant and neuroprotective effects, and nanomedicine provides boosted delivery to the brain and targeted drug distribution. In future clinical applications, these new strategies could help to more effectively and permanently manage PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicine and Engineering Interdisciplinary Research Laboratory of Nursing & Materials/ Nursing Key Laboratory of Sichuan Province, West China Hospital, Sichuan University/ West China School of Nursing, Sichuan Universit…
Zitieren
APA
Arbab, S., Ullah, H., Han, Y., Zhou, J., & Ka, L. (2026). Targeting neuroinflammation and neurodegeneration in Parkinson’s disease: Emerging natural and synthetic therapeutic strategies. Ageing Research Reviews, 121, 103263. https://doi.org/10.1016/j.arr.2026.103263
Vancouver
Arbab S, Ullah H, Han Y, Zhou J, Ka L. Targeting neuroinflammation and neurodegeneration in Parkinson’s disease: Emerging natural and synthetic therapeutic strategies. Ageing Research Reviews. 2026;121:103263. doi:10.1016/j.arr.2026.103263
BibTeX
@article{Arbab2026,
author = {Arbab, Safia and Ullah, Hanif and Han, Yanting and Zhou, Jiao and Ka, Li},
title = {Targeting neuroinflammation and neurodegeneration in Parkinson’s disease: Emerging natural and synthetic therapeutic strategies},
journal = {Ageing Research Reviews},
year = {2026},
volume = {121},
pages = {103263},
doi = {10.1016/j.arr.2026.103263}
}
EUVIMED